Clinical research funding continues to lag for the U.S. population of Asian Americans, Native Hawaiians and Pacific Islanders, even though the nation’s largest biomedical funding agency has pledged to prioritize research on diverse populations, a new study from Oregon State University shows.
“We looked at how this commitment has translated to funding and we found that things really haven’t changed,” says Ms. Lan Doan, a doctoral candidate in public health at Oregon State University College of Public Health and Human Sciences.
“Population projections indicate we are going to be a very diverse America. But if we don’t recognize the diversity with the Asian American, Native Hawaiian and Pacific Islander populations, we’re not going to have a good picture of the health outcomes for these groups,” she says.
The findings were published recently by JAMA Network Open. Co-authors include Dr. Yumie Takata, Dr.Kari-Lyn Sakuma and Dr. Veronica Irvin, all assistant professors in OSU’s College of Public Health and Human Sciences.
The National Institutes of Health (NIH) is the largest biomedical research funder in the United States and the agency has established that projects focused on diverse populations should be a priority, Ms. Lan says. Her work was designed to explore how this commitment has impacted research on Asian American, Native Hawaiian and Pacific Islander populations.
Asian American, Native Hawaiian and Pacific Islander populations are the fastest-growing racial/ethnic group in the United States and represent more than 50 countries or cultures of origin. Native Hawaiian and Pacific Islander populations are either combined with Asian Americans or excluded from studies altogether, despite the fact that they are distinct racial/ethnic groups.Friday Letter Submission, Publish on August 30